Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.66 USD | +1.22% | 0.00% | +12.93% |
13/03 | Transcript : Spero Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024 | |
13/03 | Spero Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.93% | 88.38M | |
+5.59% | 109B | |
+11.02% | 105B | |
-0.38% | 22.25B | |
-12.19% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-10.43% | 16.85B | |
+2.83% | 13.76B | |
+35.75% | 12.46B |
- Stock Market
- Equities
- SPRO Stock
- News Spero Therapeutics, Inc.
- HC Wainwright Adjusts Spero Therapeutics' Price Target to $37 From $43, Maintains Buy Rating